Abstract 28 Table 1
| Surgical (n=30) | Catheter (n=90) | p | |
|---|---|---|---|
| Age (years) | 58±9.9 | 57.9±9.8 | 0.95 |
| Male (%) | 86.7% | 80.0% | 0.41 |
| BMI (kg.m2) | 31.7±4.3 | 30.5±4.4 | 0.19 |
| eGFR | 66.7±12.8 | 68.7±17.1 | 0.60 |
| CHA2DS2VASc | 1.1±0.9 | 1.5±1.3 | 0.18 |
| EuroScore II | 0.9%±0.3% | 0.8%±0.3% | 0.61 |
| pAF (%) | 6.7% | 8.9% | 0.92 |
| perAF (%) | 50.0% | 47.8% | 0.92 |
| LSperAF (%) | 43.3% | 43.3% | 0.92 |
| AF duration (years) | 4.3±3.7 | 4.5±5.3 | 0.82 |
| DCCV (%) | 83.3% | 67.8% | 0.10 |
| Catheter ablation (%) | 6.7% | 6.7% | 1.00 |
| Ejection fraction (%) | 52.3%±6.5% | 49.6%±8.3% | 0.11 |
| LA diameter (mm) | 46.1±5 | 46.1±5.2 | 0.96 |
| LA volume (mL) | 90.8±18.4 | 98.1±32.6 | 0.46 |
| Follow up (months) | 17.4±7.1 | 15.3±8.2 | 0.21 |